Open Registration

Oct 26, 2017
Nov 28, 2017


The differential diagnosis, investigation, and staging of lymphomas will be reviewed. The biological spectrum and clinical diversity of NHL will discussed. The differences in the approach and the current standard of care for aggressive versus indolent NHL will be explored as will the role of new emerging therapies.
Pierre Laneuville, MD
Non-Hodgkins’ lymphoma, diffuse large cell lymphoma, follicular lymphoma, CT, PET-CT, chemotherapy, monoclonal antibodies, cell therapy.

[ All ] [ New ]
Live Events

Major Events

Accredited Events

From Montreal, QC, Canada
Copyright © 2002-2018 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University